Back to news

Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway

PR Newswire•06/10/2026•16:30 ET
0

Key Highlights

  • ➤Curaleaf revised hostile bid to US$5.00 per Aurora share
  • ➤Aurora Special Committee begins independent review of revised bid
  • ➤Aurora shareholders advised to take no action pending recommendation
  • ➤Curaleaf bid expires no earlier than December 4, 2026

Expert Statements

Miguel Martin, Executive Chairman and CEO of Aurora

“The filing of a revised Hostile Bid is simply the next step in the process, not a deadline to make a decision. Investors deserve the chance to review the revised Hostile Bid and decide for themselves whether it reflects the full value of the company they already own. Our Board and Special Committee are commencing their review, and until Aurora's formal recommendation is available, we urge investors to take no action”

Miguel Martin, Executive Chairman and CEO of Aurora

“Once the review is complete, the Board will communicate its recommendation and provide the relevant information to shareholders to support them in considering their options”

Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway PR Newswire

* Aurora's Special Committee will commence a thorough and independent review of the revised Hostile Bid and the Board will provide a formal recommendation to shareholders once the review is complete. * Shareholders are advised to TAKE NO ACTION pending a formal recommendation. * Aurora shareholders will have until at least December 4, 2026, to consider their options. * Questions about the Hostile Bid or would like to stay informed? Please contact Kingsdale Advisors toll-free at 1-800-749-9052 within North America, call or text 416-623-4172 or at contactus@kingsdaleadvisors.com (mailto:contactus@kingsdaleadvisors.com) . EDMONTON, AB, Oct. 6, 2026 /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) regarding the filing of a Notice of Variation and Change to revise its hostile take-over bid (the "Hostile Bid") for all of the issued and outstanding common shares of the Company (the "Aurora Shares") to offer revised implied consideration of US$5.00 per Share, consisting of 0.4013 subordinate voting shares of Curaleaf plus US$1.00 in cash per Aurora Share.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in